MannKind Corp. (MNKD)
3.66
+0.10
(+2.81%)
USD |
NASDAQ |
May 07, 10:43
MannKind Cash from Investing (Quarterly) : -291.96M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| United Therapeutics Corp. | 743.70M |
| Phathom Pharmaceuticals, Inc. | -0.061M |
| Invivyd, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| BioMarin Pharmaceutical, Inc. | 725.53M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -7.428M |
| Cash from Financing (Quarterly) | 246.88M |
| Free Cash Flow | 13.69M |
| Free Cash Flow Per Share (Quarterly) | -0.0307 |
| Free Cash Flow to Equity (Quarterly) | -256.85M |
| Free Cash Flow to Firm (Quarterly) | 1.148M |
| Free Cash Flow Yield | 1.20% |